Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | MAPT | P10636 | 4/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 3/20 | 0.58 |
| ▸ | ATM | Q13315 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.55 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.55 |
| ▸ | MME | P08473 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6795034 | 1.00 | ALDH1A1 (0.63) | ALDH1A1MAPTMEN1KMT2ARXFP1 | |
| SCHEMBL18852431 | 0.84 | ALDH1A1 (0.66) | ALDH1A1MAPTMEN1KMT2ARXFP1 | |
| SCHEMBL19425986 | 0.84 | ALDH1A1 (0.85) | ALDH1A1MAPTMEN1KMT2ARXFP1 | |
| SCHEMBL9886 | 0.84 | ALDH1A1 (0.85) | ALDH1A1MAPTMEN1KMT2ARXFP1 | |
| SCHEMBL14546953 | 0.84 | TAAR1 (0.57) | ALDH1A1MAPTMEN1KMT2ARXFP1 | |
| SCHEMBL6864880 | 0.83 | ALDH1A1 (0.63) | ALDH1A1MAPTMEN1KMT2ARXFP1 | |
| Hydrochloric Acid SCHEMBL9145715 | 0.83 | ALDH1A1 (0.81) | ALDH1A1MAPTMEN1KMT2ARXFP1 | |
| Hydrochloric Acid SCHEMBL27725869 | 0.83 | ALDH1A1 (0.81) | ALDH1A1MAPTMEN1KMT2ARXFP1 | |
| SCHEMBL11659850 | 0.83 | ALDH1A1 (0.81) | ALDH1A1MAPTMEN1KMT2ARXFP1 | |
| SCHEMBL11882145 | 0.82 | POLB (0.63) | ALDH1A1MAPTMEN1KMT2ARXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0261225-B1 | LECTIN COMPLEX AND METHOD AND PROBE FOR MAKING SAME | DANA FARBER CANCER INST INC (US) | 1995-09-27 | — | — | EP | claimed |
| US-5395924-A | Oligosaccharide or glycopeptide bound to lectin and conjugated with cell binding agent, improved targeting of cells for cytolysis | DANA-FARBER CANCER INSTITUTE, INC. (US) | 1995-03-07 | — | — | US | claimed |
| EP-0628315-A1 | Lectin complex and probe and method for making same | DANA-FARBER CANCER INSTITUTE, INC. (US) | 1994-12-14 | — | — | EP | claimed |
| EP-0537259-A1 | PROCESS FOR PRODUCING ENANTIOMERS OF 2-ARYL-ALKANOIC ACIDS | NOVO NORDISK A/S (DK) | 1993-04-21 | — | — | EP | claimed |
| EP-0261225-A4 | LECTIN COMPLEX AND METHOD AND PROBE FOR MAKING SAME. | DANA FARBER CANCER INST INC (US) | 1989-10-27 | — | — | EP | claimed |
| EP-0261225-A1 | LECTIN COMPLEX AND METHOD AND PROBE FOR MAKING SAME. | DANA FARBER CANCER INST INC (US) | 1988-03-30 | — | — | EP | claimed |
| WO-1987005515-A1 | LECTIN COMPLEX AND METHOD AND PROBE FOR MAKING SAME | DANA-FARBER CANCER INSTITUTE, INC. (US) | 1987-09-24 | — | — | WO | claimed |
| EP-4651872-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF USE TO TREAT HYPOPARATHYROIDISM AND OSTEOPOROSIS | Septerna, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| WO-2024155601-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF USE TO TREAT HYPOPARATHYROIDISM AND OSTEOPOROSIS | SEPTERNA, INC. (US) | 2024-07-25 | — | — | WO | disclosed |
| CN-117623968-A | Method for preparing N-substituted lactamide by catalyzing polylactic acid aminolysis with ionic liquid | 中国科学院化学研究所 | 2024-03-01 | — | — | CN | disclosed |
| US-11603349-B2 | Anti-fibrotic compounds | CERTA THERAPEUTICS PTY LTD (AU) | 2023-03-14 | — | — | US | disclosed |
| CN-107033102-B | The synthetic method of mefenacet | 江苏永凯化学有限公司 | 2019-07-05 | — | — | CN | disclosed |
| CN-107033102-A | The synthetic method of mefenacet | 江苏永凯化学有限公司 | 2017-08-11 | — | — | CN | disclosed |
| US-5239062-A | Blocked lectins, methods and affinity support for making same using affinity ligands, and method of killing selected cell populations having reduced nonselective cytotoxicity | DANA-FARBER CANCER INSTITUTE, INC. (US) | 1993-08-24 | — | — | US | disclosed |
| EP-0261225-A4 | LECTIN COMPLEX AND METHOD AND PROBE FOR MAKING SAME. | DANA FARBER CANCER INST INC (US) | 1989-10-27 | — | — | EP | disclosed |
| EP-0261225-A1 | LECTIN COMPLEX AND METHOD AND PROBE FOR MAKING SAME. | DANA FARBER CANCER INST INC (US) | 1988-03-30 | — | — | EP | disclosed |
| WO-1987005515-A1 | LECTIN COMPLEX AND METHOD AND PROBE FOR MAKING SAME | DANA-FARBER CANCER INSTITUTE, INC. (US) | 1987-09-24 | — | — | WO | disclosed |
| EP-0177414-A1 | Jodized triaminobenzene compounds, process for their preparation and their use in contrast products | GUERBET S.A. (FR) | 1986-04-09 | — | — | EP | disclosed |
| US-4276303-A | SYSTEMIC FUNGICIDES FOR PHYTOPATHOGENIC FUNGI | CIBA-GEIGY CORPORATION (US) | 1981-06-30 | — | — | US | disclosed |
| US-4233308-A | PHYTOPATHOGENIC FUNGICIDES | CIBA-GEIGY CORPORATION (US) | 1980-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11603349-B2 | Anti-fibrotic compounds | TGFB1, SMAD3, TGFB2 | ALDH1A1 1274/4885MAPT 3290/4885MEN1 3362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.